Search Results 131-140 of 3426 for Solid

1. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer. Print ...

2. Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

   This phase I trial studies the side effects and the best dose of navitoclax when given together with sorafenib tosylate in treating patients with solid ...

3. Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 - Mayo Clinic

   Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...

4. Solid organ transplant patients are at higher risk of skin cancer and require coordinated care, Mayo Clinic researchers find

   More than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point — most often a nonmelanoma cancer, ...

5. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors - Mayo Clinic

   The puprose of the study is to test the safety of SGN-CEACAM5C in participants with Advanced solid tumors. Participation eligibility. Participant eligibility ...

6. Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors - Mayo Clinic

   The purpose of this study is to determine if tisotumab vedotin is an effective treatment for certain solid tumors and what side effects (unwanted effects) may ...

7. A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

   Clinical Trials · A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors · More about research at Mayo Clinic · Mayo ...

8. PGY-2 Pharmacy Residency in Solid Organ Transplant at Mayo Clinic Hospital — Arizona - Application Process

   Learn about the application process for the PGY-2 Pharmacy Residency in Solid Organ Transplant at Mayo Clinic Hospital — Arizona.

9. Evaluation and Graduation - Curriculum - PGY-2 Pharmacy Residency in Solid Organ Transplant (AZ) - Mayo Clinic College of Medicine & Science

   PGY-2 Pharmacy Residency in Solid Organ Transplant at Mayo Clinic Hospital — Arizona Evaluation and Graduation · Evaluation and Graduation · College of Medicine & ...

10. Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer - Mayo Clinic

    Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, ...